Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $44.16 +1.24%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
- BMO Capital Reiterates Market Perform Rating on Progressive Corp. (PGR)
- Benchmark Reiterates Buy Rating on Synopsys (SNPS) Amid 'Relatively Bearish' Sentiment Into Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
